Mer­ck touts up­dat­ed 21-va­lent pneu­mo­coc­cal da­ta weeks ahead of FDA de­ci­sion: Cor­rect­ed

Mer­ck bol­stered its pneu­mo­coc­cal vac­cine da­ta on Mon­day, as the com­pa­ny looks to one-up Pfiz­er’s Pre­vnar 20 shot.

Mer­ck said that its new con­ju­gate vac­cine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER